// App-Quantinova.ai

: MNGI-05. DEVELOPMENT AND VALIDATION OF A DNA METHYLOME-BASED PREDICTOR OF MENINGIOMA RECURRENCE AND MENINGIOMA RECURRENCE SCORE

Researchers

Presenter

  • Christel Herold-Mende

Principal Investigators

  • Felix Sahm

  • Andreas von Deimling

  • Gelareh Zadeh

  • Kenneth Aldape

Medical Centers

  • Division of Neurosurgical Research, Heidelberg University, Germany, Heidelberg, Germany

  • University Clinic Heidelberg, Heidelberg, Germany

  • Princess Margaret Hospital, University Health Network, University of Toronto, Toronto, ON, Canada

  • Center for Cancer Research, National Cancer Institute, Bethesda, MD

Locations

  • Germany

  • Canada

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • DNA methylation

Drug/Treatment

  • Methadone hydrochloride

Outcome

  • N/A

Study Design

  • Multicenteric

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved